🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/04/2015 | 51,48 | 52,65 | 51,01 | 51,60 | +0,15% | 3,19% | 483.305 |
| 13/04/2015 | 51,78 | 52,34 | 50,97 | 51,52 | -0,73% | 2,65% | 500.938 |
| 10/04/2015 | 50,77 | 52,40 | 50,64 | 51,90 | +3,34% | 3,48% | 690.572 |
| 09/04/2015 | 50,83 | 52,22 | 49,61 | 50,22 | -0,85% | 5,14% | 481.060 |
| 08/04/2015 | 48,45 | 51,63 | 48,45 | 50,66 | +4,84% | 6,55% | 926.534 |
| 07/04/2015 | 47,21 | 49,45 | 46,51 | 48,32 | +2,35% | 6,24% | 485.709 |
| 06/04/2015 | 47,66 | 48,78 | 46,63 | 47,21 | -1,50% | 4,50% | 536.204 |
| 02/04/2015 | 48,32 | 48,93 | 47,54 | 47,92 | -0,81% | 2,89% | 609.140 |
| 01/04/2015 | 48,43 | 49,18 | 47,26 | 48,32 | +0,44% | 3,97% | 1.011.012 |
| 31/03/2015 | 47,47 | 48,70 | 47,10 | 48,10 | +1,15% | 3,36% | 680.153 |
| 30/03/2015 | 46,20 | 48,13 | 45,89 | 47,55 | +4,50% | 4,86% | 604.491 |
| 27/03/2015 | 43,99 | 45,95 | 43,91 | 45,51 | +3,77% | 4,64% | 405.078 |
| 26/03/2015 | 44,18 | 44,71 | 41,90 | 43,86 | -0,57% | 6,37% | 825.224 |
| 25/03/2015 | 47,01 | 47,12 | 43,90 | 44,10 | -5,23% | 6,85% | 656.909 |
| 24/03/2015 | 47,24 | 47,55 | 46,06 | 46,54 | -1,36% | 3,16% | 434.092 |
| 23/03/2015 | 47,27 | 47,59 | 46,09 | 47,18 | -1,40% | 3,15% | 532.196 |
| 20/03/2015 | 48,21 | 49,66 | 47,44 | 47,85 | +1,20% | 4,61% | 1.186.541 |
| 19/03/2015 | 44,76 | 47,31 | 44,57 | 47,28 | +5,44% | 6,12% | 657.070 |
| 18/03/2015 | 45,60 | 45,71 | 43,76 | 44,84 | -2,32% | 4,28% | 972.540 |
| 17/03/2015 | 46,54 | 46,74 | 45,24 | 45,91 | -1,41% | 3,22% | 827.629 |
| 16/03/2015 | 46,82 | 47,32 | 46,21 | 46,56 | -0,47% | 2,37% | 561.531 |
| 13/03/2015 | 45,15 | 46,78 | 44,15 | 46,78 | +3,86% | 5,82% | 419.826 |
| 12/03/2015 | 45,88 | 46,05 | 44,80 | 45,04 | -1,15% | 2,73% | 929.259 |
| 11/03/2015 | 45,43 | 45,98 | 44,60 | 45,56 | -0,07% | 3,03% | 774.249 |
| 10/03/2015 | 43,51 | 45,81 | 43,36 | 45,60 | +3,76% | 5,64% | 968.693 |
| 09/03/2015 | 43,63 | 44,23 | 42,46 | 43,94 | +1,34% | 4,05% | 600.324 |
| 06/03/2015 | 42,98 | 44,05 | 42,59 | 43,36 | +0,80% | 3,41% | 369.972 |
| 05/03/2015 | 42,51 | 44,69 | 42,51 | 43,02 | +2,09% | 5,11% | 716.862 |
| 04/03/2015 | 41,17 | 42,85 | 40,80 | 42,14 | +1,66% | 4,98% | 814.324 |
| 03/03/2015 | 40,55 | 42,56 | 40,43 | 41,45 | +4,51% | 5,25% | 1.602.679 |